Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
_
_  
Search: 
 
_
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Severe Acute Respiratory Syndrome (SARS)

Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2

Supplement F: Laboratory Guidance

Appendix F1— Proficiency Testing for Public Health Laboratories Providing SARS-CoV EIA and RT-PCR Diagnostics

May 3, 2005

Download PDF version formatted for print Adobe Acrobat Reader (62 KB/1 page)
Download Word version formatted for print Microsoft Word (229 KB/1 page)

CDC has developed and validated diagnostic assays for SARS-CoV, including an enzyme immunoassay (EIA) for detection of serum antibodies to SARS-CoV and a reverse transcription-polymerase chain reaction (RT-PCR) assay for detection of SARS-CoV RNA. Both the EIA and the RT-PCR tests are sensitive and highly specific for diagnosis of SARS-CoV infection. Testing with these assays is now available through state public health laboratories and CDC’s Laboratory Response Network (LRN).

CDC is in the process of developing and implementing a quality assurance program to evaluate each laboratory's testing proficiency. To demonstrate competence in performing these tests, public health and LRN laboratories will be required to successfully identify positive and negative specimens provided in the proficiency panels.

Process for Proficiency Panel Testing

  1. EIA proficiency panels will be shipped to designated public health laboratories, and RT-PCR proficiency panels will be distributed through the LRN.
  2. Each laboratory should complete testing promptly and return results by the designated date.
  3. Proficiency panel test results must be returned by electronic mail using a designated format.
  4. Each laboratory will receive a complete summary of its own results as well as an aggregate summary of performance from all laboratories completing the proficiency testing.
  5. CDC will provide a certificate of participation to the participating laboratory to help fulfill quality assurance requirements.

Results obtained from a laboratory’s proficiency testing will initially be considered “educational,” and laboratories will not be required to undergo additional training as remediation. However, successful completion of the proficiency test will be required for approval of a public health or LRN laboratory as a confirmatory testing site.


 

_
_
Topic Contents
_ arrow SARS Home
  arrow Community Containment
  arrow Evaluation/Diagnosis
  arrow Exposure Management
  arrow Infection Control
  arrow Laboratory
  arrow Legal Authorities
  arrow Preparedness Planning
  arrow References & Resources
  arrow Surveillance & Reporting
  arrow Travel
  arrow What Everyone Should Know
  arrow What's New
_
_
blackdots
_

Contact Info

Public:
English 800-CDC-INFO
Español 888-246-2857
TTY 888-232-6348
Clinician:
English 877-554-4625
_
arrow Sign up for the Clinician Registry
arrow Contact Us
_
blackdots
_
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (800) CDC-INFO